Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
Xtant Medical (NYSE: XTNT) said CEO Sean Browne, CFO Scott Neils, and COO Mark Schallenberger will participate in the Canaccord Genuity 2026 Musculoskeletal Conference on March 2, 2026, in New Orleans and virtually.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xtant Medical (NYSE: XTNT) said CEO Sean Browne, CFO Scott Neils, and COO Mark Schallenberger will participate in the Canaccord Genuity 2026 Musculoskeletal Conference on March 2, 2026, in New Orleans and virtually. A webcast will be available and management will offer virtual one-on-one meetings. A replay will be posted to Xtant's Presentation & Events page for 90 days.
Details
News Market Reaction – XTNT
On Feb 25, the day this news came out, XTNT closed 0.82% above the previous close.
Data tracked by StockTitan Argus for the Feb 25 session.
Key Figures
- Conference date
- March 2, 2026
- Canaccord Genuity 2026 Musculoskeletal Conference
- Webcast availability time
- February 2, 2:00 PM ET
- Time webcast presentation becomes available
- Replay duration
- 90 days
- Replay on Xtant’s Presentations & Events investor webpage
Historical Context
-
Launch of next‑generation nanOss Strata synthetic bone graft product.
-
Companion Spine completes acquisition of Paradigm Spine assets from Xtant.
-
Sale of Coflex assets and Paradigm OUS entities to Companion Spine for cash and note.
-
Q3 2025 results with revenue growth, higher gross margin, and positive cash flow.
-
Commercial launch of CollagenX bovine collagen particulate for surgical wound closure.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A webcast of the company's presentation will be available here as of Monday, February 2nd at 2:00 P.M. (ET). In addition, Xtant's management team will be available for virtual one-on-one meetings on that day. Interested investors should contact their representative at Canaccord Genuity. A replay of the presentation will be posted to the Presentation & Events page of Xtant's Investors website for 90 days.
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-participate-in-the-canaccord-genuity-2026-musculoskeletal-conference-302696640.html
SOURCE Xtant Medical Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.